7th Translational Research ConferenceLymphoid MalignanciesOctober 20-22, 2023 – Estoril, Portugal #ESHLYMPHOID2023 Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt REGISTRATION & ABSTRACT SUBMISSION ARE OPEN! ABOUT THE CONFERENCE: ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives.The presentation of…
7th Translational Research ConferenceLymphoid MalignanciesOctober 20-22, 2023 – Estoril, Portugal #ESHLYMPHOID2023 Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt REGISTRATION & ABSTRACT SUBMISSION ARE…
7th Translational Research ConferenceLymphoid MalignanciesOctober 20-22, 2023 – Estoril, Portugal #ESHLYMPHOID2023 Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt REGISTRATION & ABSTRACT SUBMISSION ARE…
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing…
Review Article from The New England Journal of Medicine — Burkitt’s Lymphoma
Key Points. MCD-associated genetic lesions strongly promoted accumulation of B cells in splenic germinal centers (GCs) of unimmunized miceMice engineered to har
The sensitivity of circulating tumor DNA detection is improved by identifying sequences with two or more mutations.
We combine basic research, preclinical investigation, and drug development with innovative, therapeutic clinical trials to treat lymphoid malignancies.
